193 related articles for article (PubMed ID: 10213111)
1. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans.
Cook JC; Klinefelter GR; Hardisty JF; Sharpe RM; Foster PM
Crit Rev Toxicol; 1999 Mar; 29(2):169-261. PubMed ID: 10213111
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of reappearance of luteinizing hormone receptor expression and function in rat testis after selective Leydig cell destruction by ethylene dimethane sulfonate.
Tena-Sempere M; Rannikko A; Kero J; Zhang FP; Huhtaniemi IT
Endocrinology; 1997 Aug; 138(8):3340-8. PubMed ID: 9231786
[TBL] [Abstract][Full Text] [Related]
3. PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
Crit Rev Toxicol; 2003; 33(6):655-780. PubMed ID: 14727734
[TBL] [Abstract][Full Text] [Related]
4. Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans.
Clegg ED; Cook JC; Chapin RE; Foster PM; Daston GP
Reprod Toxicol; 1997; 11(1):107-21. PubMed ID: 9138629
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
[TBL] [Abstract][Full Text] [Related]
6. Mode-of-action and human relevance framework analysis for rat Leydig cell tumors associated with sulfoxaflor.
Rasoulpour RJ; Terry C; LeBaron MJ; Stebbins K; Ellis-Hutchings RG; Billington R
Crit Rev Toxicol; 2014 May; 44 Suppl 2():25-44. PubMed ID: 24832552
[TBL] [Abstract][Full Text] [Related]
7. A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparisons with man.
Prentice DE; Meikle AW
Hum Exp Toxicol; 1995 Jul; 14(7):562-72. PubMed ID: 7576816
[TBL] [Abstract][Full Text] [Related]
8. Spermatogenesis in pre-pubertal boys with Leydig cell neoplasms suggests paracrine stimulation by testosterone.
Keefe DT; Blais AS; Rickard M; Yehia N; Chami R; Lorenzo AJ
J Pediatr Urol; 2021 Feb; 17(1):48.e1-48.e6. PubMed ID: 33129671
[TBL] [Abstract][Full Text] [Related]
9. Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.
Abiuso AMB; Varela ML; Haro Durand L; Besio Moreno M; Marcos A; Ponzio R; Rivarola MA; Belgorosky A; Pignataro OP; Berensztein E; Mondillo C
Eur J Cancer; 2018 Mar; 91():125-135. PubMed ID: 29367056
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
[TBL] [Abstract][Full Text] [Related]
11. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
Dirami G; Cooke BA
Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats.
Cook JC; Mullin LS; Frame SR; Biegel LB
Toxicol Appl Pharmacol; 1993 Apr; 119(2):195-204. PubMed ID: 8480329
[TBL] [Abstract][Full Text] [Related]
13. Induction of Leydig cell tumors by lacidipine via up-regulation of the LHRH receptor on Leydig cells in rats.
Hamada Y; Futamura Y
J Toxicol Sci; 1998 Feb; 23(1):35-52. PubMed ID: 9513920
[TBL] [Abstract][Full Text] [Related]
14. Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis.
Coulson M; Gibson GG; Plant N; Hammond T; Graham M
Toxicol Appl Pharmacol; 2003 Oct; 192(2):154-63. PubMed ID: 14550749
[TBL] [Abstract][Full Text] [Related]
15. The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: loss of testicular response.
Waalkes MP; Rehm S; Devor DE
Toxicol Appl Pharmacol; 1997 Jan; 142(1):40-6. PubMed ID: 9007032
[TBL] [Abstract][Full Text] [Related]
16. Fetal Leydig cell culture--an in vitro system for the study of trophic hormone and GnRH receptors and actions.
Dufau ML; Knox GF
J Steroid Biochem; 1985 Nov; 23(5B):743-55. PubMed ID: 3001417
[TBL] [Abstract][Full Text] [Related]
17. Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone.
Murakami M; Hosokawa S; Yamada T; Harakawa M; Ito M; Koyama Y; Kimura J; Yoshitake A; Yamada H
Toxicol Appl Pharmacol; 1995 Apr; 131(2):244-52. PubMed ID: 7716766
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486.
O'Connor JC; Davis LG; Frame SR; Cook JC
Toxicol Sci; 2000 Apr; 54(2):338-54. PubMed ID: 10774816
[TBL] [Abstract][Full Text] [Related]
19. Recombinant rat luteinizing hormone; production by Chinese hamster ovary cells, purification and functional characterization.
Hakola K; Boogaart PV; Mulders J; de Leeuw R; Schoonen W; Heyst JV; Swolfs A; Casteren JV; Huhtaniemi I; Kloosterboer H
Mol Cell Endocrinol; 1997 Apr; 128(1-2):47-56. PubMed ID: 9140075
[TBL] [Abstract][Full Text] [Related]
20. Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer.
de Peyster A; MacLean KJ; Stephens BA; Ahern LD; Westover CM; Rozenshteyn D
Toxicol Sci; 2003 Mar; 72(1):31-42. PubMed ID: 12604832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
